Hot Features
프리미엄
Artiva Biotherapeutics Inc (ARTV)
NASDAQ
실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Our product candidates are derived from donor cells (allogeneic) rather than a patients own cells (... Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Our product candidates are derived from donor cells (allogeneic) rather than a patients own cells (autologous) and are pre-manufactured, stored frozen and ready to ship to a patients treatment location, making them what we believe to be off-the-shelf. Our lead product candidate, AlloNK, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs) in an ongoing Phase 1/1b trial in class III or IV lupus nephritis (LN) and a basket investigator-initiated trial (IIT) in multiple autoimmune indications. 더 보기
Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK® in autoimmune diseases Initial data for AlloNK® in autoimmune...
SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell...
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell...
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell...
Strong balance sheet with successful completion of upsized $179.0 million initial public offering Treatment initiated in the first patient in an investigator-initiated basket trial of AlloNK®...
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.65 | -35.8546168959 | 10.18 | 10.18 | 6.52 | 81253 | 7.74247009 | CS |
| 4 | -3.37 | -34.0404040404 | 9.9 | 11.55 | 6.52 | 75268 | 9.76505904 | CS |
| 12 | -3.67 | -35.9803921569 | 10.2 | 15.49 | 6.52 | 57956 | 10.91844157 | CS |
| 26 | -9.47 | -59.1875 | 16 | 17.31 | 6.52 | 115452 | 11.91954269 | CS |
| 52 | -9.47 | -59.1875 | 16 | 17.31 | 6.52 | 115452 | 11.91954269 | CS |
| 156 | -9.47 | -59.1875 | 16 | 17.31 | 6.52 | 115452 | 11.91954269 | CS |
| 260 | -9.47 | -59.1875 | 16 | 17.31 | 6.52 | 115452 | 11.91954269 | CS |
gdog
2 분 전
jog49
4 분 전
quester614
6 분 전
fuagf
7 분 전
HomeRunSwing
9 분 전
littlejohn
9 분 전
johnydollar
9 분 전
Zorax
12 분 전
mrfence
15 분 전
mrfence
19 분 전
gimmegimmeminemine
20 분 전
gfp927z
21 분 전
Hawk05
21 분 전
gfp927z
22 분 전
mrfence
23 분 전
gfp927z
24 분 전
XMaster2023
30 분 전
gfp927z
30 분 전
dinogreeves
30 분 전
gfp927z
31 분 전
gfp927z
32 분 전
dinogreeves
33 분 전
Jimmy Joe
41 분 전
Skulls999
43 분 전
